Jianfeng Group (600668.SH) subsidiary obtained European CEP certificate for methyldopa APIs

Zhitongcaijing · 1d ago

Zhitong Finance App News, Jianfeng Group (600668.SH) issued an announcement. Recently, Anhui Jianfeng Beika Pharmaceutical Co., Ltd., a subsidiary of the company, received the European Pharmacopeia Approval Certificate for Methyldopa APIs (“CEP Certificate”) issued by the European Medicines Quality Administration. Methyldopa is a central antihypertensive drug. Obtaining the CEP certificate this time indicates that the European regulatory market recognizes and affirms the quality of this API, and indicates that this product has the qualifications to enter the EU in the form of an API and other markets that recognize the CEP certificate.